Fermi Board Files Definitive Revocation Statement, Fights Former CEO's Proxy Bid Amidst Financial Distress
Summary
Fermi Inc. has filed definitive materials to counter former CEO Toby Neugebauer's proxy solicitation, urging shareholders to revoke their consent for a Special Meeting and support the current board's "Fermi 2.0" strategy amidst a critical leadership battle.
Key Events
-
Definitive Consent Revocation Filed
Fermi Inc. filed definitive materials and mailed a letter urging shareholders to return the WHITE Consent Revocation Card to block former CEO Toby Neugebauer's attempt to call a Special Meeting.
-
Proxy Battle Escalation
The company explicitly states that Neugebauer currently lacks the required support to call a Special Meeting and accuses him of pursuing a self-interested agenda that would force a sale below intrinsic value.
-
Former CEO's Termination Details
The filing reiterates that Neugebauer was terminated for cause due to misrepresentations, policy violations, and disruptive behavior, highlighting the stock's >80% decline during his tenure.
-
"Fermi 2.0" Progress Highlighted
The board emphasizes positive momentum, including re-established relationships, expanded campus capacity, $1.0 billion in financing commitments, and an active search for a permanent CEO.
Analysis
This filing is a critical escalation in the ongoing proxy contest for control of Fermi Inc., a company facing a "going concern" warning and severe liquidity issues. The board is actively soliciting shareholder consent revocations to block former CEO Toby Neugebauer's attempt to call a Special Meeting and install his own directors. The company details Neugebauer's termination for cause and argues his actions are self-interested and value-destructive, while promoting its "Fermi 2.0" plan. The outcome of this proxy battle will determine the company's leadership and strategic direction at a pivotal time.
At the time of this filing, FRMI was trading at $7.28 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $4.47 to $36.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.